Skip to main content
Clinical Trials/NCT05917756
NCT05917756
Recruiting
N/A

The Impact of Mobilization With Movement on Pain, Function, and Quality of Life in Patients With Thoracic Outlet Syndrome: A Randomized Controlled Trial

Ahram Canadian University1 site in 1 country120 target enrollmentJuly 1, 2023

Overview

Phase
N/A
Intervention
Not specified
Conditions
Thoracic Outlet Syndrome
Sponsor
Ahram Canadian University
Enrollment
120
Locations
1
Primary Endpoint
Changes in Pain Intensity
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

This randomized controlled trial aims to evaluate the effects of Mobilization with Movement (MWM) on pain, function, and quality of life in patients with Thoracic Outlet Syndrome (TOS) compared to conventional physiotherapy.

Registry
clinicaltrials.gov
Start Date
July 1, 2023
End Date
July 1, 2024
Last Updated
2 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Mohamed Magdy ElMeligie

Lecturer of Physical Therapy and Director of Electromyography Lab

Ahram Canadian University

Eligibility Criteria

Inclusion Criteria

  • Adults aged 18-65 years, diagnosed with TOS by a specialist, and experiencing symptoms for at least 3 months

Exclusion Criteria

  • Previous surgery for TOS
  • contraindications to manual therapy
  • other comorbidities significantly affecting upper limb function

Outcomes

Primary Outcomes

Changes in Pain Intensity

Time Frame: Changes in Pain intensity at Baseline, 4 weeks, 8 weeks, and 12 weeks (follow-up)

Pain intensity will be assessed using the Numeric Pain Rating Scale (NPRS).

Secondary Outcomes

  • Changes in Quality of Life(Changes in quality of life at Baseline, 4 weeks, 8 weeks, and 12 weeks (follow-up)aseline, 4 weeks, 8 weeks, and 12 weeks (follow-up))
  • Changes in Functional Status(Changes in Functional Status Baseline, 4 weeks, 8 weeks, and 12 weeks (follow-up))
  • Changes in Cervical Range of Motion(Baseline, 4 weeks, 8 weeks, and 12 weeks (follow-up))

Study Sites (1)

Loading locations...

Similar Trials